Global Human Respiratory Disease Treatment Market Research Report 2022

  • Report ID:189925
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Apr-22
  • No. of Pages: 93
                              
Human Respiratory Disease Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Human Respiratory Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Inhalable & Nasal Spray Oral Others Segment by Application Hospital Retail Pharmacy Other By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company GSK AstraZeneca Boehringer Ingelheim Vertex Roche Novartis Teva Chiesi Viatris Sumitomo Dainippon Merck Beximco
                        
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Respiratory Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Inhalable & Nasal Spray 1.2.3 Oral 1.2.4 Others 1.3 Market by Application 1.3.1 Global Human Respiratory Disease Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Respiratory Disease Treatment Market Perspective (2017-2028) 2.2 Human Respiratory Disease Treatment Growth Trends by Region 2.2.1 Human Respiratory Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Human Respiratory Disease Treatment Historic Market Size by Region (2017-2022) 2.2.3 Human Respiratory Disease Treatment Forecasted Market Size by Region (2023-2028) 2.3 Human Respiratory Disease Treatment Market Dynamics 2.3.1 Human Respiratory Disease Treatment Industry Trends 2.3.2 Human Respiratory Disease Treatment Market Drivers 2.3.3 Human Respiratory Disease Treatment Market Challenges 2.3.4 Human Respiratory Disease Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Respiratory Disease Treatment Players by Revenue 3.1.1 Global Top Human Respiratory Disease Treatment Players by Revenue (2017-2022) 3.1.2 Global Human Respiratory Disease Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Human Respiratory Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Human Respiratory Disease Treatment Revenue 3.4 Global Human Respiratory Disease Treatment Market Concentration Ratio 3.4.1 Global Human Respiratory Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Respiratory Disease Treatment Revenue in 2021 3.5 Human Respiratory Disease Treatment Key Players Head office and Area Served 3.6 Key Players Human Respiratory Disease Treatment Product Solution and Service 3.7 Date of Enter into Human Respiratory Disease Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Respiratory Disease Treatment Breakdown Data by Type 4.1 Global Human Respiratory Disease Treatment Historic Market Size by Type (2017-2022) 4.2 Global Human Respiratory Disease Treatment Forecasted Market Size by Type (2023-2028) 5 Human Respiratory Disease Treatment Breakdown Data by Application 5.1 Global Human Respiratory Disease Treatment Historic Market Size by Application (2017-2022) 5.2 Global Human Respiratory Disease Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Human Respiratory Disease Treatment Market Size (2017-2028) 6.2 North America Human Respiratory Disease Treatment Market Size by Country (2017-2022) 6.3 North America Human Respiratory Disease Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Human Respiratory Disease Treatment Market Size (2017-2028) 7.2 Europe Human Respiratory Disease Treatment Market Size by Country (2017-2022) 7.3 Europe Human Respiratory Disease Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Human Respiratory Disease Treatment Market Size (2017-2028) 8.2 Asia-Pacific Human Respiratory Disease Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Human Respiratory Disease Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Human Respiratory Disease Treatment Market Size (2017-2028) 9.2 Latin America Human Respiratory Disease Treatment Market Size by Country (2017-2022) 9.3 Latin America Human Respiratory Disease Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Respiratory Disease Treatment Market Size (2017-2028) 10.2 Middle East & Africa Human Respiratory Disease Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Human Respiratory Disease Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Detail 11.1.2 GSK Business Overview 11.1.3 GSK Human Respiratory Disease Treatment Introduction 11.1.4 GSK Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.1.5 GSK Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Detail 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Human Respiratory Disease Treatment Introduction 11.2.4 AstraZeneca Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.2.5 AstraZeneca Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Detail 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Human Respiratory Disease Treatment Introduction 11.3.4 Boehringer Ingelheim Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Vertex 11.4.1 Vertex Company Detail 11.4.2 Vertex Business Overview 11.4.3 Vertex Human Respiratory Disease Treatment Introduction 11.4.4 Vertex Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.4.5 Vertex Recent Development 11.5 Roche 11.5.1 Roche Company Detail 11.5.2 Roche Business Overview 11.5.3 Roche Human Respiratory Disease Treatment Introduction 11.5.4 Roche Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.5.5 Roche Recent Development 11.6 Novartis 11.6.1 Novartis Company Detail 11.6.2 Novartis Business Overview 11.6.3 Novartis Human Respiratory Disease Treatment Introduction 11.6.4 Novartis Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.6.5 Novartis Recent Development 11.7 Teva 11.7.1 Teva Company Detail 11.7.2 Teva Business Overview 11.7.3 Teva Human Respiratory Disease Treatment Introduction 11.7.4 Teva Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.7.5 Teva Recent Development 11.8 Chiesi 11.8.1 Chiesi Company Detail 11.8.2 Chiesi Business Overview 11.8.3 Chiesi Human Respiratory Disease Treatment Introduction 11.8.4 Chiesi Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.8.5 Chiesi Recent Development 11.9 Viatris 11.9.1 Viatris Company Detail 11.9.2 Viatris Business Overview 11.9.3 Viatris Human Respiratory Disease Treatment Introduction 11.9.4 Viatris Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.9.5 Viatris Recent Development 11.10 Sumitomo Dainippon 11.10.1 Sumitomo Dainippon Company Detail 11.10.2 Sumitomo Dainippon Business Overview 11.10.3 Sumitomo Dainippon Human Respiratory Disease Treatment Introduction 11.10.4 Sumitomo Dainippon Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.10.5 Sumitomo Dainippon Recent Development 11.11 Merck 11.11.1 Merck Company Detail 11.11.2 Merck Business Overview 11.11.3 Merck Human Respiratory Disease Treatment Introduction 11.11.4 Merck Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.11.5 Merck Recent Development 11.12 Beximco 11.12.1 Beximco Company Detail 11.12.2 Beximco Business Overview 11.12.3 Beximco Human Respiratory Disease Treatment Introduction 11.12.4 Beximco Revenue in Human Respiratory Disease Treatment Business (2017-2022) 11.12.5 Beximco Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
                
List of Tables Table 1. Global Human Respiratory Disease Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Inhalable & Nasal Spray Table 3. Key Players of Oral Table 4. Key Players of Others Table 5. Global Human Respiratory Disease Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Human Respiratory Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Human Respiratory Disease Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Human Respiratory Disease Treatment Market Share by Region (2017-2022) Table 9. Global Human Respiratory Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Human Respiratory Disease Treatment Market Share by Region (2023-2028) Table 11. Human Respiratory Disease Treatment Market Trends Table 12. Human Respiratory Disease Treatment Market Drivers Table 13. Human Respiratory Disease Treatment Market Challenges Table 14. Human Respiratory Disease Treatment Market Restraints Table 15. Global Human Respiratory Disease Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Human Respiratory Disease Treatment Market Share by Players (2017-2022) Table 17. Global Top Human Respiratory Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Respiratory Disease Treatment as of 2021) Table 18. Ranking of Global Top Human Respiratory Disease Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Human Respiratory Disease Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Human Respiratory Disease Treatment Product Solution and Service Table 22. Date of Enter into Human Respiratory Disease Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Human Respiratory Disease Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Human Respiratory Disease Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Human Respiratory Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Human Respiratory Disease Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Human Respiratory Disease Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Human Respiratory Disease Treatment Revenue Market Share by Application (2017-2022) Table 30. Global Human Respiratory Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Human Respiratory Disease Treatment Revenue Market Share by Application (2023-2028) Table 32. North America Human Respiratory Disease Treatment Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Human Respiratory Disease Treatment Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Human Respiratory Disease Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Human Respiratory Disease Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Human Respiratory Disease Treatment Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Human Respiratory Disease Treatment Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Human Respiratory Disease Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Human Respiratory Disease Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Human Respiratory Disease Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Human Respiratory Disease Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. GSK Company Detail Table 43. GSK Business Overview Table 44. GSK Human Respiratory Disease Treatment Product Table 45. GSK Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 46. GSK Recent Development Table 47. AstraZeneca Company Detail Table 48. AstraZeneca Business Overview Table 49. AstraZeneca Human Respiratory Disease Treatment Product Table 50. AstraZeneca Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 51. AstraZeneca Recent Development Table 52. Boehringer Ingelheim Company Detail Table 53. Boehringer Ingelheim Business Overview Table 54. Boehringer Ingelheim Human Respiratory Disease Treatment Product Table 55. Boehringer Ingelheim Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 56. Boehringer Ingelheim Recent Development Table 57. Vertex Company Detail Table 58. Vertex Business Overview Table 59. Vertex Human Respiratory Disease Treatment Product Table 60. Vertex Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 61. Vertex Recent Development Table 62. Roche Company Detail Table 63. Roche Business Overview Table 64. Roche Human Respiratory Disease Treatment Product Table 65. Roche Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 66. Roche Recent Development Table 67. Novartis Company Detail Table 68. Novartis Business Overview Table 69. Novartis Human Respiratory Disease Treatment Product Table 70. Novartis Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 71. Novartis Recent Development Table 72. Teva Company Detail Table 73. Teva Business Overview Table 74. Teva Human Respiratory Disease Treatment Product Table 75. Teva Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 76. Teva Recent Development Table 77. Chiesi Company Detail Table 78. Chiesi Business Overview Table 79. Chiesi Human Respiratory Disease Treatment Product Table 80. Chiesi Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 81. Chiesi Recent Development Table 82. Viatris Company Detail Table 83. Viatris Business Overview Table 84. Viatris Human Respiratory Disease Treatment Product Table 85. Viatris Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 86. Viatris Recent Development Table 87. Sumitomo Dainippon Company Detail Table 88. Sumitomo Dainippon Business Overview Table 89. Sumitomo Dainippon Human Respiratory Disease Treatment Product Table 90. Sumitomo Dainippon Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 91. Sumitomo Dainippon Recent Development Table 92. Merck Company Detail Table 93. Merck Business Overview Table 94. Merck Human Respiratory Disease TreatmentProduct Table 95. Merck Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 96. Merck Recent Development Table 97. Beximco Company Detail Table 98. Beximco Business Overview Table 99. Beximco Human Respiratory Disease TreatmentProduct Table 100. Beximco Revenue in Human Respiratory Disease Treatment Business (2017-2022) & (US$ Million) Table 101. Beximco Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Respiratory Disease Treatment Market Share by Type: 2021 VS 2028 Figure 2. Inhalable & Nasal Spray Features Figure 3. Oral Features Figure 4. Others Features Figure 5. Global Human Respiratory Disease Treatment Market Share by Application in 2021 & 2028 Figure 6. Hospital Case Studies Figure 7. Retail Pharmacy Case Studies Figure 8. Other Case Studies Figure 9. Human Respiratory Disease Treatment Report Years Considered Figure 10. Global Human Respiratory Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Human Respiratory Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Human Respiratory Disease Treatment Market Share by Region: 2021 VS 2028 Figure 13. Global Human Respiratory Disease Treatment Market Share by Players in 2021 Figure 14. Global Top Human Respiratory Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Respiratory Disease Treatment as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Human Respiratory Disease Treatment Revenue in 2021 Figure 16. North America Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Human Respiratory Disease Treatment Market Share by Country (2017-2028) Figure 18. United States Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Human Respiratory Disease Treatment Market Share by Country (2017-2028) Figure 22. Germany Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Human Respiratory Disease Treatment Market Share by Region (2017-2028) Figure 30. China Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Human Respiratory Disease Treatment Market Share by Country (2017-2028) Figure 38. Mexico Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Human Respiratory Disease Treatment Market Share by Country (2017-2028) Figure 42. Turkey Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Human Respiratory Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. GSK Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 45. AstraZeneca Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 46. Boehringer Ingelheim Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 47. Vertex Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 48. Roche Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 49. Novartis Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 50. Teva Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 51. Chiesi Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 52. Viatris Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 53. Sumitomo Dainippon Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 54. Merck Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 55. Beximco Revenue Growth Rate in Human Respiratory Disease Treatment Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Purchase Report

Single User 2900
Multi User 4350
Corporate User 5800
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.